Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622

Longva AS, Berg K, Weyergang A (2024)
Corrigendum: Light-enhanced VEGF₁₂₁/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment
Front Immunol, 14, 1359973
DOI 10.3389/fimmu.2023.1359973, PubMed 38264651

Longva AS, Berg K, Weyergang A (2023)
Light-enhanced VEGF₁₂₁/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment
Front Immunol, 14, 1278000
DOI 10.3389/fimmu.2023.1278000, PubMed 38173721